431 related articles for article (PubMed ID: 36082469)
21. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
22. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma.
Cheng X; Zeng Z; Yang H; Chen Y; Liu Y; Zhou X; Zhang C; Wang G
BMC Cancer; 2023 Jan; 23(1):105. PubMed ID: 36717792
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
Song S; Zhang M; Xie P; Wang S; Wang Y
Front Immunol; 2022; 13():978909. PubMed ID: 36341328
[TBL] [Abstract][Full Text] [Related]
24. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
[TBL] [Abstract][Full Text] [Related]
25.
Wu L; Liu Y; Deng W; Wu T; Bu L; Chen L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629087
[TBL] [Abstract][Full Text] [Related]
26. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
[TBL] [Abstract][Full Text] [Related]
27. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
28. Landscape and the immune patterns of cuproptosis in oral squamous cell carcinoma.
Yuan D; Li XQ; Qu FW; Wang Y
J Oral Pathol Med; 2023 Nov; 52(10):951-960. PubMed ID: 37828627
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
Zhang S; Zhang W; Zhang J
Oral Oncol; 2022 Mar; 126():105755. PubMed ID: 35144208
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.
Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L
BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403
[TBL] [Abstract][Full Text] [Related]
31. Identification of cuproptosis and ferroptosis-related subgroups and development of a signature for predicting prognosis and tumor microenvironment landscape in hepatocellular carcinoma.
Yang BF; Ma Q; Hui Y; Gao XC; Ma DY; Li JX; Pei ZX; Huang BR
Transl Cancer Res; 2023 Dec; 12(12):3327-3345. PubMed ID: 38192999
[TBL] [Abstract][Full Text] [Related]
32. A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma.
Liu R; Liu Y; Zhang F; Wei J; Wu L
Front Immunol; 2023; 14():1146411. PubMed ID: 37063920
[TBL] [Abstract][Full Text] [Related]
33. DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma.
Gao F; Yuan Y; Ding Y; Li PY; Chang Y; He XX
Curr Med Sci; 2023 Jun; 43(3):526-538. PubMed ID: 37286711
[TBL] [Abstract][Full Text] [Related]
34. Association of cuproptosis-related signature with the prognosis of patients with head and neck squamous cell carcinoma.
Li Y; Sun C; Gu F; Yue J; Huang X; Yuan B; Wang Y; Chen R
J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38279934
[TBL] [Abstract][Full Text] [Related]
35. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
[TBL] [Abstract][Full Text] [Related]
36. Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma.
Wang L; Wang D; Yang L; Zeng X; Zhang Q; Liu G; Pan Y
Front Immunol; 2022; 13():989286. PubMed ID: 36618352
[TBL] [Abstract][Full Text] [Related]
37. Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma.
Shan J; Geng R; Zhang Y; Wei J; Liu J; Bai J
Comput Biol Med; 2022 Oct; 149():105988. PubMed ID: 36007289
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
40. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
